Does KarXT (xanomeline-trospium) represent a novel approach to schizophrenia management? A GRADE-assessed systematic review and meta-analysis of randomized controlled clinical trials.
Saved in:
| Title: | Does KarXT (xanomeline-trospium) represent a novel approach to schizophrenia management? A GRADE-assessed systematic review and meta-analysis of randomized controlled clinical trials. |
|---|---|
| Authors: | Mohammed, Hazem E.1 (AUTHOR) Hazemeslam25@gmail.com, Gomaa, Menna A.2 (AUTHOR) menaayman058@gmail.com, Khalifa, Youssef Magdy2 (AUTHOR) yousofkhalifa@gmail.com, Shawky, Ahmed Ayman2,3 (AUTHOR) ahmed.ayman196700@gmail.com |
| Source: | BMC Psychiatry. 4/1/2025, Vol. 25 Issue 1, p1-15. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1471244X |
|---|---|
| DOI: | 10.1186/s12888-025-06696-5 |
